Discontinued — last reported Q1 '18
Tapestry, Inc. Allowance for Doubtful Accounts Receivable (Current) decreased by 13.9% to $6.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $5.60M to $6.20M. Over 4 years (FY 2021 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 7.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.20M | $4.50M | $3.70M | $4.30M | $3.70M | $3.30M | $4.60M | $6.20M | $5.80M | $5.80M | $5.90M | $5.80M | $6.90M | $7.10M | $6.40M | $5.60M | $5.70M | $5.80M | $7.20M | $6.20M |
| QoQ Change | — | +7.1% | -17.8% | +16.2% | -14.0% | -10.8% | +39.4% | +34.8% | -6.5% | +0.0% | +1.7% | -1.7% | +19.0% | +2.9% | -9.9% | -12.5% | +1.8% | +1.8% | +24.1% | -13.9% |
| YoY Change | — | — | — | — | -11.9% | -26.7% | +24.3% | +44.2% | +56.8% | +75.8% | +28.3% | -6.5% | +19.0% | +22.4% | +8.5% | -3.4% | -17.4% | -18.3% | +12.5% | +10.7% |